These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31260682)

  • 21. AEBP1 Contributes to Breast Cancer Progression by Facilitating Cell Proliferation, Migration, Invasion, and Blocking Apoptosis.
    Li J; Ruan Y; Zheng C; Pan Y; Lin B; Chen Q; Zheng Z
    Discov Med; 2023 Feb; 35(174):45-56. PubMed ID: 37024441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.
    Liu X; Kong C; Zhang Z
    Oncol Rep; 2018 May; 39(5):2324-2332. PubMed ID: 29512748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
    Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
    Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
    Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SMAR1 inhibits proliferation, EMT and Warburg effect of bladder cancer cells by suppressing the activity of the Wnt/β-catenin signaling pathway.
    Bao P; Li P; Zhou X; Zhang H; You S; Xu Z; Wu Q
    Cell Cycle; 2023 Jan; 22(2):229-241. PubMed ID: 35980125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
    Zhou X; Zhang P; Han H; Lei H; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling.
    Wu Q; Zhou X; Li P; Ding M; You S; Xu Z; Ye J; Chen X; Tan M; Wang J; Wang W; Qiu J
    J Exp Clin Cancer Res; 2021 May; 40(1):158. PubMed ID: 33962660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals.
    Ou Z; Wang Y; Liu L; Li L; Yeh S; Qi L; Chang C
    Oncotarget; 2015 Sep; 6(28):26065-78. PubMed ID: 26305549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway.
    Xiao S; Chen J; Wei Y; Song W
    Eur J Med Res; 2024 May; 29(1):302. PubMed ID: 38811952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma.
    Zhu W; Wang Y; Zhang D; Yu X; Leng X
    Biochem Biophys Res Commun; 2018 Mar; 497(4):963-970. PubMed ID: 29408481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9.
    Gao Y; Guan Z; Chen J; Xie H; Yang Z; Fan J; Wang X; Li L
    Int J Oncol; 2015 Aug; 47(2):690-700. PubMed ID: 26058729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals.
    Tao L; Qiu J; Slavin S; Ou Z; Liu Z; Ge J; Zuo L; Guancial EA; Messing EM; Chang C; Yeh S
    Cancer Lett; 2018 Aug; 430():215-223. PubMed ID: 29684419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
    Cheng Y; Yang X; Deng X; Zhang X; Li P; Tao J; Lu Q
    Tumour Biol; 2015 Sep; 36(10):8015-23. PubMed ID: 25967457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of N-Myc downstream-regulated gene 2 (NDRG2) regulates the proliferation and invasion of bladder cancer cells in vitro and in vivo.
    Li R; Yu C; Jiang F; Gao L; Li J; Wang Y; Beckwith N; Yao L; Zhang J; Wu G
    PLoS One; 2013; 8(10):e76689. PubMed ID: 24146910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
    Jiang W; Zhu D; Wang C; Zhu Y
    Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOX18 meditates the resistance of Bmi1-expressing cells to cetuximab in HNSCC.
    Zhang C; Chen Z; Gao N; Xiong G; Chen P; Li H; Chen D; He Q; Peng L
    Oral Dis; 2024 Apr; 30(3):1100-1113. PubMed ID: 37184032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX18 knockdown suppresses the proliferation and metastasis, and induces the apoptosis of osteosarcoma cells.
    Wu Z; Liu J; Wang J; Zhang F
    Mol Med Rep; 2016 Jan; 13(1):497-504. PubMed ID: 26573263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.
    Piao XM; Hwang B; Jeong P; Byun YJ; Kang HW; Seo SP; Kim WT; Lee JY; Ha YS; Lee YS; Kim IY; Choi YH; Cha EJ; Moon SK; Yun SJ; Kim WJ
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.
    Pula B; Olbromski M; Wojnar A; Gomulkiewicz A; Witkiewicz W; Ugorski M; Dziegiel P; Podhorska-Okolow M
    Cell Oncol (Dordr); 2013 Dec; 36(6):469-83. PubMed ID: 24065215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.